Potassium sodium hydrogen citrate
- Generic Name
- Potassium sodium hydrogen citrate
- Drug Type
- Small Molecule
- Chemical Formula
- C12H12K3Na3O15
- CAS Number
- 55049-48-4
- Unique Ingredient Identifier
- X6T6YN87SU
- Indication
用于溶解尿酸结石和防止新结石形成，作为胱氨酸结石和胱氨酸尿的维持治疗。
- Associated Conditions
- Uric Acid Stones, Urolithiasis, Calcium Oxalate, Cystine renal calculi
The Effective of Potassium Sodium Hydrogen Citrate in Treating Uric Acid Stones Using Gut Microbiota and Metabolomics.
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Cheng Cao
- Target Recruit Count
- 30
- Registration Number
- NCT06118320
- Locations
- 🇨🇳
Changshu Hospital Affiliated to Soochow University, Changshu City, Jiangsu, China
Role of Uralyt-U in Patients With Hyperuricemia
- First Posted Date
- 2020-04-20
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- Ai Peng
- Target Recruit Count
- 102
- Registration Number
- NCT04352153
- Locations
- 🇨🇳
Department of Nephrolgoy, Shanghai 10th People's Hospital, Shanghai, Shanghai, China
Treatment of Renal Stones With Frankincense (Luban)
Phase 1
- Conditions
- Renal Stones
- Interventions
- Drug: AKBA-Incense (3-acetyl-11-keto-ß-boswellic acid)
- First Posted Date
- 2019-04-23
- Last Posted Date
- 2019-04-29
- Lead Sponsor
- Sultan Qaboos University
- Target Recruit Count
- 100
- Registration Number
- NCT03924596
- Locations
- 🇴🇲
Mohamed Salim Ahmed Al-Marhoon, Muscat, Oman
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath